Subaortic and mid-ventricular obstructive hypertrophic cardiomyopathy with an apical aneurysm: a case report

Tomás Francisco Cianciulli1, María Cristina Saccheri, Isabel Victoria Konopka

  • 1Department of Cardiology, Hospital del Gobierno de la Ciudad de Buenos Aires Dr, Cosme Argerich, Buenos Aires, Argentina. tcianciulli@fibertel.com.ar

Insights

This rare case report details a patient with hypertrophic cardiomyopathy (HCM) exhibiting both mid-ventricular and apical variants, alongside an apical aneurysm. This unique combination, presenting with myocardial infarction and normal coronary arteries, highlights unusual HCM manifestations.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Genetics

Background:

  • Hypertrophic cardiomyopathy (HCM) commonly presents with asymmetric septal hypertrophy, often leading to dynamic subaortic obstruction in 25% of cases.
  • Apical and mid-ventricular HCM are rare variants, sometimes associated with apical aneurysms.
  • The coexistence of mid-ventricular and apical HCM is exceptionally infrequent.

Observation:

  • A 49-year-old female patient presented with combined septal asymmetric HCM and midventricular HCM.
  • She exhibited a subaortic gradient of 65 mm Hg and a midventricular gradient of 20 mm Hg, along with an apical aneurysm.
  • Clinical presentation included acute myocardial infarction, normal coronary arteries, and left ventricular hypertrophy.

Findings:

  • The patient had a rare combination of obstructive HCM, mid-ventricular HCM, and an apical aneurysm.
  • Coronary angiography revealed no coronary artery disease, despite the myocardial infarction.
  • Electrocardiogram showed a right bundle branch block without ST-segment elevation or Q waves post-infarction.

Implications:

  • This case represents a unique presentation of hypertrophic cardiomyopathy, previously unreported in medical literature.
  • It underscores the importance of considering rare HCM variants and their potential complications, such as apical aneurysms.
  • Further research into the genetic and pathophysiological mechanisms of these rare HCM presentations is warranted.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...